Worldwide sales of the controlled substances closed in on a valuation of US$ 67,000 Mn in 2018, and are projected to record a Y-o-Y growth at 3.5% in 2019, according to a new Fact.MR study. The study opines that depressants and stimulants have been top-selling class of drugs in the controlled substances market, however gains from marijuana are expected to record over 2X faster growth than all the other controlled substances in 2019 and beyond.
Approval of medical marijuana has been on a significant uptick in various states of the US, trailed by the legalization in Canada for both recreational and medicinal use recently. This has tremendously contributed to the popularity of cannabis stocks, alongside efforts of leading controlled substance manufacturers toward eliminating legal barriers and attracting investor interest. The study estimates marijuana sales in 2019 to
... read more at: https://www.openpr.com/news/1743476/Controlled-Substances-Market-Forecast-Covering-Growth-Inclinations-Development-Strategies-until-2028-Key-Players-CANNABIS-SATIVA-INC-The-Peace-Naturals-Project-Canopy-Growth-Corporation-GW-PHARMACEUTICALS-PLC.html